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Background: Low concentrations of nitric oxide (NO) are necessary for the biology and physiology of spermatozoa,
but high levels of NO are toxic and have negative effects on sperm functions. Although several studies have
considered the relationship between infertility and semen NO concentrations, no study on the effects of
asthenospermia treatments such as oral zinc supplementation on concentrations of NO, which are important in
fertility, has been reported. Studies have shown that oral zinc supplementation develops sperm count, motility and
the physical characteristics of sperm in animals and in some groups of infertile men. The present study was
conducted to study the effect of zinc supplementation on the quantitative and qualitative characteristics of semen,
along with enzymes of the NO pathway in the seminal plasma of asthenospermic patients.
Methods: Semen samples were obtained from 60 fertile and 60 asthenozoospermic infertile men of matched age.
The subfertile group was treated with zinc sulfate; each participant took two capsules (220 mg per capsule) per day
for 3 months. Semen samples were obtained (before and after zinc sulfate supplementation). After liquefaction of
the seminal fluid at room temperature, routine semen analyses were performed. The stable metabolites of NO
(nitrite) in seminal plasma were measured by nitrophenol assay. Arginase activity and NO synthase activity were
measured spectrophotometrically.
Results: Peroxynitrite levels, arginase activity, NO synthase activity and various sperm parameters were compared
among fertile controls and infertile patients (before and after treatment with zinc sulfate). Peroxynitrite levels and
NO synthase activity were significantly higher in the infertile patients compared to the fertile group. Conversely,
arginase activity was significantly higher in the fertile group than the infertile patients. Peroxynitrite levels, arginase
activity and NO synthase activity of the infertile patient were restored to normal values after treatment with zinc
sulfate. Volume of semen, progressive sperm motility percentage and total normal sperm count were increased
after zinc supplementation.
Conclusions: Treatment of asthenospermic patients with zinc supplementation leads to restored peroxynitrite
levels, arginase activity and NO synthase activity to normal values and gives a statistically significant improvement
of semen parameters compared with controls.
Trial registration: ClinicalTrials.gov identifier: NCT01684059
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Infertility is defined as the lack of ability to conceive
within 1 year of unprotected intercourse with the same
partner [1]. It is estimated that nearly 13–15% of couples
are infertile [2]. As a result of this prevalence, couples
proceed to recognize either partner’s responsibility. Half
of these infertile couples involve a component of male
infertility [3]. Male subfertility commonly comprises a
status in which the incapability to conceive is related to
an alteration present in the male partner [4].
There are several causes leading to male infertility,
such as oxidative stress or nutritional insufficiency of
trace elements, i.e., selenium and zinc (Zn) [5,6]. The
trace element Zn is second only to iron as the most
abundant element in the human tissues. Although Zn is
found in most types of foods such as red meat, white
meat, fish, and milk, the World Health Organization
(WHO) estimates that one-third of the world population
is deficient in Zn [7]. Zinc serves as a cofactor for more
than 80 metallic enzymes concerned in cellular develop-
ment processes such as DNA transcription and protein
synthesis; for this reason, Zn is expected to be important
for reproduction. Zinc is essential for testicular steroido-
genesis, testicular development, synthesis and secretion
of luteinizing hormone and follicle stimulating hormone,
testosterone synthesis, gonadal differentiation, formation
and maturation of spermatozoa, acrosome reaction,
acrosin activity, and fertilization [8,9]. Also, Zn has anti-
apoptotic [10] and antioxidant properties [11]. Ozturk et al.
[12] have indicated that Zn deficiency in rats results in
atrophy of seminiferous tubules and interruption of
spermatogenesis. Lewis-Jones et al. [13] pointed to the
involvement of Zn in functions that are important for
sperm physiology such as sperm membrane integrity,
increased sperm motility and regulation of the spiral
movements of the sperm tail.
O2 is required to support the life of spermatozoa, but
its metabolites, such as reactive oxygen species (ROS),
have some disadvantages, which include modification of
cellular functions and/or threaten cell survival [14]. For
this reason, ROS formation must be regulated to sustain
only the necessary amount that suitable for maintaining
normal cellular function.Table 1 Ejaculate parameters of seminal fluids of infertile pat
Volume (mL) Sperm count (×106
Healthy donors G1 2.8 ± 0.53 77 ± 9
Patients before treatment G2 1.83 ± 0.66* 47 ± 21*
(P-value = 0.042) (P-value = 0.023)
Patients after treatment G3 2.39 ± 0.9** 70 ± 15
(P-value = 0.037) (P-value = 0.03)
Sn1*: significance versus group I (Healthy donors).
Sn2**: significance versus group II (Patients before treatment).A sequence of enzymatic and non-enzymatic antioxi-
dants normally protects the spermatozoa against oxi-
dants [15]. A major source of the antioxidant enzymes
in the ejaculate is the male accessory sex gland secre-
tions, which have been shown to be responsible for pre-
serving sperm DNA integrity from oxidative stress
experienced in the uterine environment [16].
Nitric oxide (NO) is a free radical that is formed by
most tissues of the human body and participates in a
wide range of biological processes [17]. NO is synthe-
sized through the enzymatic conversion of L-arginine to
L-citrulline by the action of one of the isoenzymes
known as nitric oxide synthase (NOS), and is concerned
with diverse physiological functions in various organs,
including the human male reproductive tracts [18,19].
Several studies have been done to recognize the function
of NO in the male reproductive tract after discovery of a
unique isoform of NOS as testis-specific nNOS (TnNOS)
[20]. A specific conclusion from these studies suggests that
NO in low levels is necessary to complete a group of male
reproductive functions such as spermatogenesis, spermio-
genesis, sperm motion, acrosome reaction, sperm/oocyte
fusion and sperm capacitation [21-23]. On the other hand,
high levels of NO have injurious effects on sperm proper-
ties such as motility, morphology and DNA stability
[24,25]. Also, high levels of NO act to increase apoptosis
and lipid peroxidation [26,27].
Given the key role of oxidative stress in the pathogenesis
of male subfertility, treatment strategies with the purpose
of reducing levels of seminal oxidative stress are required
for the assisted reproduction outcome and natural preg-
nancy. Many antioxidant treatments have been used in the
hope of developing sperm quality. A wide range of therap-
ies have been used over the years consisting of many
different vitamins, such as vitamins A, E and C, and
compounds, including carnitines, phosphatidylcholine,
kallikrein and pentoxifylline, without particular interest to
neutralize the lipoperoxidative injury [28].
Studies have shown that oral Zn supplementation de-
velops sperm count, motility and the physical character-
istics of sperm in animals [29,30], and in some groups of
infertile men [31-33]. The present study was conducted
to examine the effects of Zn supplementation on theients (n = 60) and healthy donor (n = 60) (Mean ± SD)
) Progressive sperm motility (%) Normal sperm form (%)
69 ± 8 38 ± 9
21 ± 9* 21 ± 11
(P-value = 0.00) (P-value = 0.052)
39 ± 14** 33 ± 7**
(P-value = 0.05) (P-value = 0.041)
Table 3 NOS activity (nM/108 Spermatozoa/hr) in














G1 30.10 14.49 1.87 21.73 38.46 1 2 0.007*
3 0.549
G2 57.36 14.65 1.89 33.89 80.83 2 1 0.007*
3 0.028*
G3 35.80 10.65 1.37 29.90 41.70 3 1 0.549
2 0.028*
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along with peroxynitrite levels, arginase activity and NO




Iraq: Ethics Committee (University of Babylon/ College
of Science), Reference number of approval: 545 Date:
22/6/ 2011.
Patients
This study included 60 subfertile male partners from
couples who had consulted the infertility clinic of the
Babil Hospital of Maternity (Hilla City, Iraq) from July
2011 to July 2012. The approval of the institutional re-
search ethics committee and signed written consent of
every patient included in the study was obtained. A de-
tailed medical history was taken and physical examin-
ation was performed. Subjects currently on any
medication or antioxidant supplementation were not in-
cluded. The inclusion criteria were asthenozoospermia,
the absence of endocrinopathy, varicocele and female
partner infertility. Smokers and alcoholic men were ex-
cluded from the study because of their recognized high
seminal ROS levels and decreased antioxidant levels.
The selection criteria of the fertile group were the absence
of asthenozoospermia, endocrinopathy, varicocele and
having a birth in the last year. Semen samples were ob-
tained (before and after Zn sulfate supplementation). After
liquefaction of the seminal fluid at room temperature, rou-
tine semen analyses including semen volume, pH, concen-
tration, sperm motility, normal sperm morphology and
round cells were performed according to the 2010 WHO
recommendation [34].
Preparation of seminal plasma and spermatozoa for
biochemical analysis
For each sample, seminal plasma was separated from the
spermatozoa 1 h after semen collection by centrifugationTable 2 NOS activity (nM/mg protein/hr) in seminal














G1 10.01 2.94 0.38 8.44 12.58 1 2 0.014*
3 0.818
G2 28.49 11.25 1.45 8.83 48.15 2 1 0.014*
3 0.037*
G3 9.93 2.87 0.37 7.15 13.70 3 1 0.818
2 0.037*of 2 mL of seminal fluid at 1500 × g for 10 min at 4°C and
maintained at −30°C until analysis. The pellet was resus-
pended in 10 volumes of NTPC medium [113 mM NaCl
(0.66 g/100 mL), 2.5 mM NaH2PO4 (0.3 g/100 mL),
2.5 mM Na2HPO4 (0.0355 g/100 mL), 1.7 mM CaCl2
(0.0188 g/100 mL), 1.5 mM D-glucose (0.0027 g/100 mL),
20 mM Tris (0.242 g/100 mL), 0.4 mM EDTA (0.0148
g/100 mL) adjusted to pH 7.4 with HCl] and centrifuged at
1500 × g for 10 min at 4°C. This washing procedure was re-
peated three times. Triton X-100 (0.1%) was added to the
pellets obtained and the samples centrifuged again at 4000
Xg for half an hour in a refrigerated centrifuge. This concen-
tration of Triton X-100 does not affect enzyme levels. The
supernatant was used for measurements in spermatozoa.
The samples were classified into three groups called
group I (G1, healthy donors), group II (G2, patients before
treatment) and group III (G3, patients after treatment).
After that, the samples were frozen (−20°C) until analyzed.
Chemicals
All reagents and chemicals were of analytical grade and
obtained from standard commercial suppliers.
Biochemical procedures
Nitric oxide synthase: The assay for NOS is based on
the quantitative conversion of oxyhemoglobin toTable 4 Arginase activity (U/L) in seminal plasma of














G1 149 49.56 6.39 112.55 187.36 1 2 0.022*
3 0.713
G2 106 37.06 4.78 82.05 130.24 2 1 0.022*
3 0.05*
G3 143 23.52 3.03 133.12 152.99 3 1 0.713
2 0.05*
Table 7 Peroxynitrite concentrations (μmol/ 108















G1 18.34 6.43 0.83 12.66 20.01 1 2 0.012*
3 0.970
G2 49.76 15.81 2.04 42.00 77.52 2 1 0.012*
3 0.014*
G3 20.77 6.33 0.81 15.14 26.41 3 1 0.970
2 0.014*
*The mean difference is significant at the 0.05 level.
Table 5 Arginase activity (U/108 spermatozoa) in














G1 31.25 6.30 0.81 24.80 37.70 1 2 0.023*
3 0.820
G2 18.98 7.15 0.92 11.73 26.22 2 1 0.023*
3 0.015*
G3 32.45 7.50 0.96 22.94 41.95 3 1 0.820
2 0.015*
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photometrically as a decrease in absorbance [35].
Arginase activity: Arginase activity was then deter-
mined by the spectrophotometric method described by
Geyer and Dabich [36]. One unit of arginase activity is
defined as one micromole of urea released per minute
at 37°C.
Peroxynitrite determination: The sample containing
peroxynitrite was added to phenol in 50 mM sodium
phosphate buffer (pH 7.4) mediated nitration of phenol,
after incubation for 2 h at 37°C; NaOH was added to
produce the salt nitrophenol, which has a maximum ab-
sorbance at 412 nm [37]. The yield of nitrophenol was
calculated from ε 4400 M−1 cm−1 as an index of peroxy-
nitrite concentrations.Statistical analysis
Data analysis was performed using SPSS 16 for Windows
(SPSS Inc., Chicago, IL, USA). Data were expressed as
mean, SD, SE and range, were evaluated by one-way
analysis of variance (ANOVA). The Kolmogorov-
Smirnov test was used to verify if data followed normal
distribution. Correlations between numeric data were
measured with Pearson’s correlation of coefficient. Stat-
istical significance level was considered at P < 0.05.Table 6 Peroxynitrite concentrations (μmol/L) in seminal














G1 33.63 13.14 1.69 27.09 40.17 1 2 0.030*
3 0.912
G2 44.29 19.43 2.5 34.62 53.95 2 1 0.030*
3 0.023*
G3 33.1 7.94 7.94 29.15 37.05 3 1 0.912
2 0.023*Results
The results in Table 1 indicate the baseline characteris-
tics of the semen parameters depicted in the fertile (G1)
and subfertile groups (before [G2] and after treatment
[G3] with Zn sulfate). These parameters significantly de-
creased in the infertile group [G2] compared with the
healthy donor group [G1] (P < 0.05). However, the level of
the semen parameters significantly increased (returned to
normal values) after zinc sulfate supplementation [G3]
compared with subfertile group before treatment [G2]
(P < 0.05).
The results of the present study (Tables 2, 3, 4, 5, 6, 7)
show a decrease in arginase activity, an increase in NOS
activity and an elevation in peroxynitrite levels in sperm-
atozoa and seminal plasma of patients (G2) compared
with the healthy group (G1). This difference was statisti-
cally significant (P < 0.05). However, Zn supplementation
restored to normal ranges the arginase activity, NOS ac-
tivity and elevation of peroxynitrite levels in spermato-
zoa and seminal plasma in the subfertile men (G3).
(Table 8) shows correlation analyses between progressive
motility with peroxynitrite levels, arginase activity and
NO synthase activity.
Discussion
NO is documented as a novel moderator of sperm func-
tion [38] through the modulation of sexual and repro-
ductive functions in mammals [19]. The production ofTable 8 Correlation analyses between progressive




p-value r-value p-value r-value
NOS activity 0.008 −0.82 0.009 −0.85
Arginase activity 0.043 0.89 0.009 0.87
Peroxynitrite concentrations 0.041 −0.78 0.008 −0.83
Figure 1 Formation of peroxynitrite ion (Equation 1) and its conjugate acid, peroxynitrous acid (Equation 2).
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ductive organs or macrophages has been established
[19,20]. NO itself is a weak oxidant. However, NO can
be altered to an effective oxidant by reaction with super-
oxide to produce the peroxynitrite ion (–OO-N =O) and
its conjugate acid, peroxynitrous acid (HOO-N =O)
[39], as shown in Figure 1.
Peroxynitrite can react under physiological conditions
with electron-rich compounds, such as thiols [40], iron-
sulfur centers [41] and zinc-thiolates (metallothioneins)
[42]. However, peroxynitrite has a strong one or two
electron oxidant and acts as a nitrating agent [43]. It has
unexpected stability in solutions because of its strongly
oxidizing potential and that it is 36 kcal/mol higher in
energy than its isomer nitrate. Folding into a cis-
conformation stabilizes peroxynitrite where the negative
charge is localized over the entire molecule [44]. In
addition, the formation of strong hydrogen bonds with
two or three water molecules increased its stability. The re-
stricted reactivity of peroxynitrite with most biological mol-
ecules makes it unusually selective as an oxidant, which
enhances its influence over biological pathways [44].
In the present study, peroxynitrite levels were higher
in seminal plasma of patients with asthenozoospermia,
and were negatively associated with concentrations and
rapid progressive motility of spermatozoa, as shown in
Table 8. These results confirm previous studies [45-47],
which suggest that higher NO levels in seminal plasma
are correlated with poor sperm quality. Chung et al. [48]
suggest that NO inhibits sperm motility via the forma-
tion of peroxynitrite. This inhibition depends on theFigure 2 Biosynthetic pathway for production of polyamine.production of superoxide from human semen because
peroxynitrite is generated by the interaction of NO and
superoxide.
The normal function of NO includes neutralized free
radicals to avoid the reduction of sperm motility medi-
ated by ROS. However, extreme formation of NO under
stress conditions may be harmful and could inhibit
sperm motility. Sperm motility is sustained by high con-
centrations of adenosine triphosphate. It is known that
NO acts to decline adenosine triphosphate levels in cells
by reduction in the glycolysis pathway and the electron-
transport chain [49].
The rate of NO production may be critically
dependent on the availability of arginine, with elevated
arginine availability potentially leading to increase NO
synthesis. Under physiological conditions, although the
Km of the NOS isoforms for arginine is much greater
than that of arginase, mammalian arginase competes
with NO synthase for the common substrate L-arginine
[50], to form urea and L-ornithine. Consequently, argi-
nase can regulate cellular NO synthesis and counteract
the biological effects of NO [51,52]. High activity of the
arginase enzyme is very important for improving semen
quality because it leads to increased polyamines concen-
trations via consume arginine (Figure 2).
Polyamines are ubiquitous organic polycationic com-
pounds typically included in cell replication and diffe-
rentiation. These compounds are synthesized from
L-ornithine, a nonstandard amino acid involved in the
urea cycle by the catalytic activity of ornithine decarboxyl-
ase, the rate-limiting enzyme in the biosynthesis of
Figure 3 Suggested pathological roles of NO include lipid peroxidation, DNA damage, protein oxidation, and membrane impairment.
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atozoa, seminal plasma [54] and epididymis [55], in addition
to other tissues of the male reproductive system [56].
Srivastava et al. [57] demonstrated that L-arginine
supplementation in the culture medium inhibits seminal
lipid peroxidation. The probability exists that spermato-
zoa perform this consequence by synthesizing poly-
amines, which would need arginase activity, because
polyamines protect several tissues against lipid peroxida-
tion [58]. Polyamines exert their cellular effects through
the ability to bind nucleic acids and proteins and have
been demonstrated to reduce an apoptotic state in hu-
man endometrial RL95-2 cells [59]. In addition, L-
arginine itself acts as valuable factor for polyamines in
causing enhancement of sperm cell motility [54,60]. The
complete inhibition of arginase also prevents polyamine
biosynthesis in other tissues [61].Figure 4 Detoxification of peroxynitrite by thiol and antioxidants enzThe results of the present study (Tables 2, 3, 4, 5, 6)
show a decrease in arginase activity, an increase in NOS
activity and elevation of peroxynitrite levels. The study
suggests that elevated arginine levels could be beyond
the lowering of arginase activity. This leads to a relative
accumulation of peroxynitrite, the main toxic anion of
peroxidation formed from NO. Thus, the high NOS ac-
tivity could be illustrated directly by the high arginine
content found in the semen of patients with astheno-
zoospermia, given that arginine is a substrate of this en-
zyme. Therefore, high arginine content necessitates high
NOS activity, which may produce increased oxidative
stress inclination, as shown in Figure 3.
ROS generation and oxidative status after treatment of
asthenozoospermia with zinc sulphate has been studied
in detail in our previous studies [33,62] for same pa-
tients. These studies were conducted to study the effectymes.
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tive characteristics of semen along with total antioxidant
capacity, antiperoxidant activity and lipid peroxidation
in seminal plasma of asthenospermic patients. Semen
samples were obtained from fertile and asthenozoosper-
mic infertile men with matching age. The subfertile
group was treated with zinc sulfate. Total antioxidant
capacity and antiperoxidant activity of fertile controls
was significantly higher than that of the infertile patient
group. These parameters were significantly elevated in
the infertile group which treated with zinc sulfate. Lipid
peroxidation has opposite behavior.
Zinc supplementation raises arginase activity in the
seminal plasma of asthenozoospermic patients to normal
values, potentially because of its improvement in the
synthesis of metallothioneins (low molecular weight Zn
binding protein) that have antioxidant properties [63].
The suitable mechanism of the implication of metal-
lothioneins in the enhancing the quality of seminal fluids
was illustrated in previous study [32], which used gel fil-
tration of seminal plasma on Sephadex G-75 for deter-
mination the amount of zinc binding proteins of fertile
and asthenozoospermic infertile men. The subfertile
group consists of the patients which treated with zinc
sulfate. The results of the study indicated that zinc sup-
plementation improves the synthesis of zinc binding
proteins such as metallothioneins in seminal plasma of
asthenozoospermic subjects [33]. Metallothioneins pro-
tect biological tissues from damage of oxidative stress
via capture harmful oxidant species like the superoxide
and hydroxyl radicals [64].
Hrabak et al. [65] have documented that arginase is
inhibited by nitrite, a stable end product of NO. Peroxy-
nitrite will preferably react with reduced thiols (RSH)
such as metallothioneins (R-Zn-SH) to produce thiol
radicals and sulfenic acid derivatives [66]. These com-
pounds are active and react rapidly with RSH to produce
oxidized thiol. Figure 4 elucidates the detoxification of
peroxynitrite via R-Zn-SH that are synthesized after zinc
supplementation (modified from Calabrese et al. [67]).
Thus, the obtainable information supports the fact that
although high NO levels are injurious to sperm, low and
controlled levels of NO are essential in optimizing spe-
cific pathways in sperm physiology.
Conclusions
Zinc supplementation restores arginase and NOS activity
and elevates peroxynitrite levels in spermatozoa and
seminal plasma of asthenozoospermic subjects to normal
ranges. Zinc supplementation enhances the quantitative
and qualitative properties of semen.
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